Blood Gas News and Research

RSS

Blood-flow fMRI to be used to study brain-wide impact of neural circuitry changes

Like a motorist who knows that the "check engine" light indicates something important but ill-defined is happening, neuroscientists have relied heavily on an incompletely understood technology called functional magnetic resonance imaging to show them what the brain is doing when people respond to different stimuli.

17 May 2010

FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF

The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.

5 May 2010

Skin-colored hospital gowns can help detect cyanosis

Changing the hue of hospital gowns and bed sheets to match a patient's skin color could greatly enhance a physician's ability to detect cyanosis and other health-related skin color changes, according to a new study from Rensselaer Polytechnic Institute.

30 Apr 2010

UIC introduces new "no stress" diagnostic system for heart failure assessment

The University of Illinois Medical Center at Chicago is the first academic medical center in the country to introduce a new "no stress" diagnostic system for assessing patients with heart failure and optimizing their treatment.

30 Apr 2010

Study: Lower blood oxygen levels can lead to heart abnormalities in children with sickle cell disease

Children with sickle cell disease who also have lower blood oxygen levels while both asleep and awake are likely to have heart abnormalities, researchers at Washington University School of Medicine in St. Louis and other institutions have found.

28 Apr 2010

New FDA approved Landon Medical PC-60C2 Finger Pulse Oximeter introduced for home use

PulseOximetersDIRECT.com, the leading online retailer of portable Pulse Oximeter products introduces today the new FDA approved Landon Medical PC-60C2 Finger Pulse Oximeter for home use.

26 Apr 2010

Long-term monitoring and education needed to protect lungs of young patients

St. Jude Children's Research Hospital investigators have identified childhood cancer survivors who are at increased risk for deteriorating lung health, in part due to the lifesaving bone marrow transplants they underwent years earlier.

16 Apr 2010

CAS Medical Systems granted Japanese patent for LASER-SIGHT technology in FORE-SIGHT Oximeter

CAS Medical Systems, Inc. today announced that that the Japanese Patent Office has granted a new patent for the Company's LASER-SIGHT® technology used in the FORE-SIGHT® Oximeter.

13 Apr 2010

Raised levels of carbon dioxide in blood may lead to ‘near death experiences’

Near death experiences (NDEs), reported to include sensations such as life flashing before the eyes, feelings of peace and joy, and apparent encounters with mystical entities, may be caused by raised levels of carbon dioxide in the blood. Researchers writing in BioMed Central's open access journal Critical Care investigated the unexplained events in 52 cardiac arrest patients.

8 Apr 2010

Siemens Healthcare Diagnostics announces new contract with Premier Purchasing Partners

Siemens Healthcare Diagnostics announces a new three-year contract with Premier Purchasing Partners, L.P., the group purchasing unit of Premier Inc., that includes Siemens powerful integrated diagnostic systems, several specialty diagnostic instruments, and a comprehensive menu of diagnostic tests for Premier's more than 2,300 member hospitals and 64,000 additional healthcare sites.

29 Mar 2010

Biophotonics: Light to cure disease

Biophotonics, or photomedicine, is a relatively unknown discipline, though it has existed for years now. You may have even benefited from it without realizing it. Some of the greatest advances of this field can be found in applications for the areas of oncology, dermatology, ophthalmology, surgery and cardiology.

27 Mar 2010

Sorin Group's newest generation C5 HLM system receives FDA clearance

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today the U.S. Food and Drug Administration (FDA) clearance of its newest generation C5 Heart-Lung Machine (HLM).

18 Feb 2010

Study shows severe OSA suppresses cognitive experience of nightmare recall

A study in the Feb. 15 issue of the Journal of Clinical Sleep Medicine shows that patients with severe obstructive sleep apnea (OSA) report a significantly lower frequency of nightmares than patients with mild or no sleep apnea, indicating that OSA suppresses the cognitive experience of nightmare recall.

15 Feb 2010

Vision of mountain climbers not adversely affected despite presence of edema at altitudes up to 6,300 meters

Swelling commonly occurs in the corneas of mountain climbers, but does not appear to affect vision at altitudes of up to 6,300 meters (about 20,670 feet), according to a report in the February issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

10 Feb 2010

Study assesses gray matter concentration deficits in multiple brain areas of people with OSA

A study in the Feb. 1 issue of the journal SLEEP found gray matter concentration deficits in multiple brain areas of people with severe obstructive sleep apnea (OSA). The study suggests that the memory impairment, cardiovascular disturbances, executive dysfunctions, and dysregulation of autonomic and respiratory control frequently observed in OSA patients may be related to morphological changes in brain structure.

1 Feb 2010

NovaSom Diagnostic System approved for diagnostic evaluation of adults with OSA

Some 18-20 million Americans are at risk for Obstructive Sleep Apnea (OSA) and of those, only 5 to 10 percent have been diagnosed. Studies prove that fatality is a major risk of undiagnosed and untreated OSA; however, once detected, OSA can be readily and successfully treated.

29 Jan 2010

Fourth-quarter and fiscal year 2009 results announced by Somanetics

Somanetics Corporation today reported financial results for the fourth fiscal quarter and year ended November 30, 2009.

21 Jan 2010

Masimo Rad-57 Pulse CO-Oximeter helps detect CO poisoning on-the-scene

Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that the U.S. Department of Homeland Security recently issued a Federal warning about the increased risk of carbon monoxide exposure during the winter season—urging heightened awareness and precaution for firefighters, who are at increased risk of duty-related CO danger. The life-threatening consequences of CO poisoning make immediate detection, helped by the noninvasive Masimo Rad-57 Pulse CO-Oximeter, a lifesaving necessity for fire and emergency operations.

20 Jan 2010

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.

7 Jan 2010

Inverness Medical Innovations and Epocal enter into distribution agreement

Inverness Medical Innovations, Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has entered into a distribution agreement with Epocal Inc. of Ottawa, Canada to distribute its epoc® Blood Analysis System for blood gas and electrolyte testing.

6 Jan 2010